CCR2 deficiency promotes exacerbated chronic erosive neutrophil-dominated chikungunya virus arthritis.
Chikungunya virus (CHIKV) is a member of a globally distributed group of arthritogenic alphaviruses that cause weeks to months of debilitating polyarthritis/arthralgia, which is often poorly managed with current treatments. Arthritic disease is usually characterized by high levels of the chemokine CCL2 and a prodigious monocyte/macrophage infiltrate. Several inhibitors of CCL2 and its receptor CCR2 are in development and may find application for treatment of certain inflammatory conditions, including autoimmune and viral arthritides. Here we used CCR2(-/-) mice to determine the effect of CCR2 deficiency on CHIKV infection and arthritis. Although there were no significant changes in viral load or RNA persistence and only marginal changes in antiviral immunity, arthritic disease was substantially increased and prolonged in CCR2(-/-) mice compared to wild-type mice. The monocyte/macrophage infiltrate was replaced in CCR2(-/-) mice by a severe neutrophil (followed by an eosinophil) infiltrate and was associated with changes in the expression levels of multiple inflammatory mediators (including CXCL1, CXCL2, granulocyte colony-stimulating factor [G-CSF], interleukin-1β [IL-1β], and IL-10). The loss of anti-inflammatory macrophages and their activities (e.g., efferocytosis) was also implicated in exacerbated inflammation. Clear evidence of cartilage damage was also seen in CHIKV-infected CCR2(-/-) mice, a feature not normally associated with alphaviral arthritides. Although recruitment of CCR2(+) monocytes/macrophages can contribute to inflammation, it also appears to be critical for preventing excessive pathology and resolving inflammation following alphavirus infection. Caution might thus be warranted when considering therapeutic targeting of CCR2/CCL2 for the treatment of alphaviral arthritides.


OBJECTIVE
Here we describe the first analysis of viral arthritis in mice deficient for the chemokine receptor CCR2. CCR2 is thought to be central to the monocyte/macrophage-dominated inflammatory arthritic infiltrates seen after infection with arthritogenic alphaviruses such as chikungunya virus. Surprisingly, the viral arthritis caused by chikungunya virus in CCR2-deficient mice was more severe, prolonged, and erosive and was neutrophil dominated, with viral replication and persistence not being significantly affected. Monocytes/macrophages recruited by CCL2 thus also appear to be important for both preventing even worse pathology mediated by neutrophils and promoting resolution of inflammation. Caution might thus be warranted when considering the use of therapeutic agents that target CCR2/CCL2 or inflammatory monocytes/macrophages for the treatment of alphaviral (and perhaps other viral) arthritides. Individuals with diminished CCR2 responses (due to drug treatment or other reasons) may also be at risk of exacerbated arthritic disease following alphaviral infection.
QIMR Berghofer Medical Research Institute and Australian Infectious Diseases Research Centre, Brisbane, QLD, Australia School of Medicine, University of Queensland, Brisbane, QLD, Australia.
Yee Suan
YS
Poo
School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil, and Emory Vaccine Center at Yerkes National Primate Research Center and Emory University, Atlanta, Georgia, USA.
Helder
H
Nakaya
QIMR Berghofer Medical Research Institute and Australian Infectious Diseases Research Centre, Brisbane, QLD, Australia.
Joy
J
Gardner
Institut National de Recherche Agronomique, Unité Mixte de Recherche 703, Oniris, Nantes, France.
Thibaut
T
Larcher
QIMR Berghofer Medical Research Institute and Australian Infectious Diseases Research Centre, Brisbane, QLD, Australia.
Wayne A
WA
Schroder
QIMR Berghofer Medical Research Institute and Australian Infectious Diseases Research Centre, Brisbane, QLD, Australia.
Thuy T
TT
Le
QIMR Berghofer Medical Research Institute and Australian Infectious Diseases Research Centre, Brisbane, QLD, Australia.
Lee D
LD
Major
QIMR Berghofer Medical Research Institute and Australian Infectious Diseases Research Centre, Brisbane, QLD, Australia Andreas.Suhrbier@qimrberghofer.edu.au.
Andreas
A
Suhrbier
D018354:Alphavirus Infections / Q000235:genetics / Q000276:immunology* / Q000821:virology; D000818:Animals; D001168:Arthritis / Q000235:genetics / Q000276:immunology* / Q000821:virology; D065632:Chikungunya Fever; D002646:Chikungunya virus / Q000235:genetics / Q000502:physiology*; D016179:Granulocyte Colony-Stimulating Factor / Q000276:immunology; D006801:Humans; D016753:Interleukin-10 / Q000276:immunology; D053583:Interleukin-1beta / Q000276:immunology; D051379:Mice; D018345:Mice, Knockout; D020556:Neutrophil Infiltration; D009504:Neutrophils / Q000276:immunology*; D054390:Receptors, CCR2 / Q000172:deficiency* / Q000235:genetics / Q000276:immunology
C515335:Ccr2 protein, mouse; D053583:Interleukin-1beta; D054390:Receptors, CCR2; D016753:Interleukin-10; D016179:Granulocyte Colony-Stimulating Factor